UK Approves First Oral Weight Loss Medication

Updated at: June 15, 2026 at 02:30 AM

On June 11, 2026, the UK made a significant medical breakthrough with the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first oral GLP-1 receptor agonist for weight management.

nounJune

nounUK

nounbreakthrough

verbapprove

This new daily tablet version of semaglutide, branded as Wegovy, offers an alternative for patients who prefer pills over the previously required weekly injections.

nountablet

This development is expected to make obesity treatment more accessible and less daunting for many.

nounobesity

While currently available only through private prescription, the drug is intended for adults with a BMI of 30 or above, or those with a BMI of 27 to 30 with weight-related health conditions.

adjectiveavailable

To ensure effectiveness, the medication must be taken on an empty stomach after fasting for eight hours.

verbfast

While effective—clinical trials showed a 13.6% average weight loss over 64 weeks—patients should expect common gastrointestinal side effects like nausea or diarrhea.

nounnausea

This approval represents a major step forward in obesity care, provided it is managed safely through professional pharmacy channels.

nounobesity

adverbsafely

🎉

End of article

You read 7 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary difference between the newly approved Wegovy tablet and Rybelsus?

They are both identical medications with different brand names.

Wegovy is approved for weight management, while Rybelsus is licensed for type 2 diabetes.

Wegovy is for diabetes while Rybelsus is for weight management.

Reveal Answer

✓

Correct Choice

Wegovy is approved for weight management, while Rybelsus is licensed for type 2 diabetes.

How must the new daily weight-loss tablet be consumed to ensure proper absorption?

It must be crushed and dissolved in a glass of juice.

It must be taken whole on an empty stomach after at least eight hours of fasting.

It should be taken with a large meal to prevent nausea.

Reveal Answer

✓

Correct Choice

It must be taken whole on an empty stomach after at least eight hours of fasting.

Who is eligible to be prescribed this new oral medication?

Adults with a BMI of 30 or above, or those with a BMI of 27–30 with a weight-related comorbidity.

Any adult who wants to lose weight regardless of their BMI.

Children under the age of 18 who struggle with obesity.

Reveal Answer

✓

Correct Choice

Adults with a BMI of 30 or above, or those with a BMI of 27–30 with a weight-related comorbidity.

What is one major concern expressed by health authorities regarding this new medication?

The drug will be available for free on the NHS immediately.

The pill is significantly less effective than the injectable version.

The potential rise of a black market selling counterfeit versions of the medication.

Reveal Answer

✓

Correct Choice

The potential rise of a black market selling counterfeit versions of the medication.

What were the results of the 64-week study on the 25 mg dose of this medication?

Participants experienced an average 13.6% reduction in body weight.

Participants gained an average of 13.6% body weight.

There was no significant difference compared to the placebo group.

Reveal Answer

✓

Correct Choice

Participants experienced an average 13.6% reduction in body weight.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play